These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22387553)

  • 1. Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells.
    Chang CC; Zhang QY; Liu Z; Clynes RA; Suciu-Foca N; Vlad G
    J Immunol; 2012 Apr; 188(7):3042-52. PubMed ID: 22387553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3.
    Vlad G; Suciu-Foca N
    Exp Mol Pathol; 2012 Dec; 93(3):294-301. PubMed ID: 23018130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allospecific CD8 T suppressor cells induced by multiple MLC stimulation or priming in the presence of ILT3.Fc have similar gene expression profiles.
    Chen L; Xu Z; Chang C; Ho S; Liu Z; Vlad G; Cortesini R; Clynes RA; Luo Y; Suciu-Foca N
    Hum Immunol; 2014 Feb; 75(2):190-6. PubMed ID: 24220571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells.
    Chang CC; Vlad G; D'Agati VD; Liu Z; Zhang QY; Witkowski P; Torkamani AA; Stokes MB; Ho EK; Cortesini R; Suciu-Foca N
    J Immunol; 2010 Nov; 185(10):5714-22. PubMed ID: 20935202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILT3.Fc inhibits the production of exosomes containing inflammatory microRNA in supernatants of alloactivated T cells.
    Xu Z; Ho S; Chang CC; Liu Z; Li M; Vasilescu ER; Clynes RA; Vlad G; Suciu-Foca N
    Hum Immunol; 2014 Aug; 75(8):756-9. PubMed ID: 24862932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
    Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
    Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene profile analysis of CD8(+) ILT3-Fc induced T suppressor cells.
    Vlad G; King J; Chang CC; Liu Z; Friedman RA; Torkamani AA; Suciu-Foca N
    Hum Immunol; 2011 Feb; 72(2):107-14. PubMed ID: 20974207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of T lymphocyte activation by microRNA-21.
    Wang L; He L; Zhang R; Liu X; Ren Y; Liu Z; Zhang X; Cheng W; Hua ZC
    Mol Immunol; 2014 Jun; 59(2):163-71. PubMed ID: 24631982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells.
    Kim-Schulze S; Scotto L; Vlad G; Piazza F; Lin H; Liu Z; Cortesini R; Suciu-Foca N
    J Immunol; 2006 Mar; 176(5):2790-8. PubMed ID: 16493035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-18b modulates insulin-like growth factor-1 expression in deer antler cell proliferation by directly targeting its 3' untranslated region.
    Hu W; Li M; Hu R; Li T; Meng X
    DNA Cell Biol; 2015 Apr; 34(4):282-9. PubMed ID: 25756952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.
    Chandran PA; Keller A; Weinmann L; Seida AA; Braun M; Andreev K; Fischer B; Horn E; Schwinn S; Junker M; Houben R; Dombrowski Y; Dietl J; Finotto S; Wölfl M; Meister G; Wischhusen J
    J Leukoc Biol; 2014 Oct; 96(4):633-45. PubMed ID: 25030422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
    Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of recombinant ILT3.
    Vlad G; Liu Z; Zhang QY; Cortesini R; Suciu-Foca N
    Int Immunopharmacol; 2006 Dec; 6(13-14):1889-94. PubMed ID: 17161342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation.
    Xue F; Li H; Zhang J; Lu J; Xia Y; Xia Q
    Genes Immun; 2013 Mar; 14(2):127-31. PubMed ID: 23303246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
    Baglìo SR; Devescovi V; Granchi D; Baldini N
    Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.